SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

J Korean Med Sci. 2007;22(1):26-9.

The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results.

, , , , , , , ,

제1저자 조준성 · 교신저자 임재준

소속 (1)
  1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Although mycobacterial culture and the subsequent drug-susceptibility test (DST) for anti-tuberculosis (TB) drugs take several months to complete using solid media, there are no reports on the turnaround times of these tests under clinical conditions. The aim of this study was to determine the interval between initiation of anti-TB treatment and receipt of DST requested at an outpatient clinic. We prospectively enrolled patients with culture-positive pulmonary TB at Seoul National University Hospital from September 2002 to December 2004. Patients were followed up monthly. Mycobacterial cultures were done using Ogawa media at Seoul National University Hospital. DST were performed at the Korean Institute of Tuberculosis. Of the 104 patients enrolled, 54 were male. The median age was 41 yr. The median interval from initiation of anti-TB treatment to receipt of mycobacterial culture results by clinicians was 37 days (range, 0-89 days). The median interval from initiation of treatment to confirmation of DST by requesting clinicians was 80.5 days (range, 28-145 days). Clinicians only received the results of DST more than two months after initiation of treatment when they followed up patients monthly and mycobacterial culture was performed using solid media.

Figures

Fig. 1
Fig. 1 Intervals related to the transmission of the results of drug-susceptibility tests. All numbers in this figure represent days. *When anti-TB treatment was started after receipt of the result of positive mycobacterial culture, the interval was regarded as 0 days. †Drug-susceptibility test.
Fig. 2
Fig. 2 Monthly receipt of the results of drug-susceptibility tests after initiation of the anti-TB treatment by clinicians *Drug-susceptibility test, †Months mean duration of anti-tuberculosis treatment.

그림 출처: PubMed Central 공개 논문 (PMC2693564)

그 밖의 정보
출판 형태
Journal Article
저널
Journal of Korean medical science · ISSN 1011-8934
MeSH
Adolescent · Adult · Aged · Antitubercular Agents / pharmacology / therapeutic use · Female · Humans · Male · Microbial Sensitivity Tests* · Middle Aged · Prospective Studies · Time Factors · Tuberculosis, Pulmonary / drug therapy
Substances
Antitubercular Agents
참고문헌
17편